| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.405 | 27.867 | 37.303 | 42.358 | 54.263 | 51.515 | 62.246 | 55.682 | 60.686 |
| Total Income - EUR | - | 13.405 | 27.867 | 37.303 | 42.443 | 54.263 | 51.515 | 62.246 | 55.682 | 60.686 |
| Total Expenses - EUR | - | 12.215 | 29.314 | 33.863 | 40.237 | 50.565 | 48.530 | 56.099 | 64.003 | 62.468 |
| Gross Profit/Loss - EUR | - | 1.190 | -1.448 | 3.440 | 2.206 | 3.698 | 2.984 | 6.147 | -8.320 | -1.782 |
| Net Profit/Loss - EUR | - | 787 | -1.726 | 3.067 | 1.782 | 3.196 | 2.531 | 5.614 | -8.798 | -2.641 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Vetaal Med Point Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 2.967 | 2.509 | 4.304 | 6.568 | 9.432 | 11.996 | 12.863 | 11.877 | 9.328 |
| Current Assets | - | 5.994 | 4.227 | 5.265 | 5.007 | 5.014 | 5.923 | 13.107 | 5.603 | 6.420 |
| Inventories | - | 2.404 | 2.781 | 2.400 | 2.906 | 2.102 | 2.498 | 4.687 | 3.152 | 3.162 |
| Receivables | - | 0 | 0 | 0 | 0 | 23 | 9 | 0 | 0 | 248 |
| Cash | - | 3.590 | 1.446 | 2.865 | 2.100 | 2.889 | 3.416 | 8.419 | 2.451 | 3.010 |
| Shareholders Funds | - | 832 | -908 | 2.175 | 3.915 | 7.037 | 9.412 | 15.055 | 6.211 | 3.535 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 8.128 | 7.665 | 7.411 | 7.660 | 7.410 | 8.508 | 10.915 | 11.270 | 12.213 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Vetaal Med Point Srl